Variation in Sleep Time and Glucose Variation in Patients with Type 2 Diabetes Mellitus
Phase 3
- Conditions
- non-insulin dependent diabetes mellitus
- Registration Number
- RBR-6wg54rb
- Lead Sponsor
- niversidade Federal de Minas Gerais
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
This project will include patients diagnosed with diabetes mellitus type 2 for more than one year; age greater than or equal to 40 years; family history of diabetes mellitus type 2; glycosylated haemoglobin between 7 and 10%
Exclusion Criteria
Pregnancy; corticosteroids use within less than 3 months; or other medications that elevate glycemia; diseases that significantly alter glycemia stability (renal failure, acute coronary syndrome, cancer, liver failure, among others); uncontrolled diabetes, with polydipsia, polyuria, or weight loss requiring insulin or other drugs; high risk for severe sleep apnea; depression; shift work; epilepsy; refusal to participate in this research at any time
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A reduction in capillary blood glucose variability is expected. We will calculate the differences between pre- and postprandial glycemia. we will then make a comparison between the sum of these differences in the period that the patient used melatonin and in the period that he used placebo. We will assess whether this difference was statistically significant using the Student's T test for unpaired samples
- Secondary Outcome Measures
Name Time Method